Evidence map›Paper›PMID 25645914›Full record

ArticleThe Journal of biological chemistry2015

Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations.

David M Hudson, Kyu Sang Joeng, Rachel Werther, Abbhirami Rajagopal, MaryAnn Weis, Brendan H Lee, David R Eyre

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Evidence for the major role of PH4⍺EFB in the prolyl 4-hydroxylation of Drosophila collagen IV.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Article
  4. Collagen IV biosynthesis: Intracellular choreography of post-translational modifications.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  5. Article
  6. Comprehensive analysis of the effects ofFrontiers in cell and developmental biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Prolyl 3-Hydroxylase 2 Is a Molecular Player of Angiogenesis.International journal of molecular sciences · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David M HudsonFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and.
Kyu Sang Joengthe Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030.
Rachel WertherFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and.
Abbhirami Rajagopalthe Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030.
MaryAnn WeisFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and.
Brendan H Leethe Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030.
David R EyreFrom the Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, Washington 98195 and deyre@u.washington.edu.
University of Washington · USBaylor College of Medicine · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
UNDERSTANDING FXTAS AMONG MALES WITH THE FMR1 PREMUTATIONP30HD024064 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI TOLIAS, KIMBERLY R · 1988 to 2013
$29.4M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
THE SKELETAL DYSPLASIASP01HD022657 · NICHD · CEDARS-SINAI MEDICAL CENTER · PI RIMOIN, DAVID L · 1987 to 2011
$17.0M
Project 3: Collagen post-translational modification and cross-linking in OIP01HD070394 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · 2011 to 2020
$13.4M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, SAMACO, RODNEY C · 2014 to 2019
$7.8M
Collagen Cross-linking in Skeletal Aging and DiseaseR37AR037318 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 2010 to 2019
$3.4M
PATHOLOGY OF INBORN SKELETAL DISEASESR01AR037318 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 1986 to 2009
$3.4M
Collagens of Cartilage and the Intervertebral DiscR01AR036794 · NIAMS · UNIVERSITY OF WASHINGTON · PI EYRE, DAVID R · 1986 to 2014
$3.3M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
The Function of PEDF in Recessive Osteogenesis ImperfectaF32AR063616 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI JOENG, KYU SANG · 2012 to 2014
$156k
NCI NIH HHS P30 CA125123NCRR NIH HHS RR024574NCRR NIH HHS S10 RR024574NIAID NIH HHS AI036211NIAID NIH HHS P30 AI036211NIAMS NIH HHS AR063616NIAMS NIH HHS AR37318NIAMS NIH HHS AR37694NIAMS NIH HHS F32 AR063616NIAMS NIH HHS R01 AR036794NIAMS NIH HHS R01 AR037318NIAMS NIH HHS R37 AR037318NICHD NIH HHS HD070394NICHD NIH HHS HD22657NICHD NIH HHS P01 HD022657NICHD NIH HHS P01 HD070394NICHD NIH HHS P30 HD024064NICHD NIH HHS U54 HD083092NIDDK NIH HHS T32 DK060445
6 · The paper itself

Abstract

Myopia, the leading cause of visual impairment worldwide, results from an increase in the axial length of the eyeball. Mutations in LEPREL1, the gene encoding prolyl 3-hydroxylase-2 (P3H2), have recently been identified in individuals with recessively inherited nonsyndromic severe myopia. P3H2 is a member of a family of genes that includes three isoenzymes of prolyl 3-hydroxylase (P3H), P3H1, P3H2, and P3H3. Fundamentally, it is understood that P3H1 is responsible for converting proline to 3-hydroxyproline. This limited additional knowledge also suggests that each isoenzyme has evolved different collagen sequence-preferred substrate specificities. In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type mice to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain myopia. The mice were viable and had no gross musculoskeletal phenotypes. Tissues from sclera and cornea (type I collagen) and lens capsule (type IV collagen) were dissected from mouse eyes, and multiple sites of prolyl 3-hydroxylation were identified by mass spectrometry. The level of prolyl 3-hydroxylation at multiple substrate sites from type I collagen chains was high in sclera, similar to tendon. Almost every known site of prolyl 3-hydroxylation in types I and IV collagen from P3h2(n/n) mouse eye tissues was significantly under-hydroxylated compared with their wild-type littermates. We conclude that altered collagen prolyl 3-hydroxylation is caused by loss of P3H2. We hypothesize that this leads to structural abnormalities in multiple eye tissues, but particularly sclera, causing progressive myopia.

Indexed as

Amino Acid SequenceAnimalsCollagen Type ICollagen Type IVCorneaGenetic Predisposition to DiseaseHumansHydroxylationLens Capsule, CrystallineMice, Inbred C57BLMice, KnockoutMolecular Sequence DataMutationMyopiaOrgan SpecificityPhenotypeCollagen Type ICollagen Type IVLEPREL1 protein, mouseP3H2 protein, humanProcollagen-Proline Dioxygenase3-HydroxyprolineAnimal ModelCollagenExtracellular MatrixMass Spectrometry (MS)Post-translational Modification (PTM)Prolyl 3-HydroxylaseSclera

Identifiers

PMID25645914
PMCPMC4375510
OpenAlexW2077126162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.